Freenome (FRNM) vs Lumexa Imaging (LMRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 11, 2026.
Summary
Freenome is the larger company by market cap ($1.70 billion vs $1.01 billion), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FRNM | LMRI |
|---|---|---|
| Share price | $15.78 | $10.54 |
| Market cap | $1.70B | $1.01B |
| 1-day change | -0.19% | +2.03% |
| YTD return | +21.11% | -43.03% |
| 1-year return | +48.45% | — |
| Forward P/E | — | 11.84 |
| EPS (TTM) | $-2.04 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $837.47K | — |
| 52-week high | $17.50 | $19.45 |
| 52-week low | $9.95 | $6.45 |
| Distance from 52-week high | -9.83% | -45.81% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +14.07% | +67.65% |
| Average volume | 802.26K | 431.43K |
| Shares outstanding | 107.45M | 96.07M |
| Employees | 375 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Freenome
FRNM stock →Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.
Health Care · Medical Specialities · 375 employees
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
FRNM vs LMRI FAQ
Which is bigger, Freenome or Lumexa Imaging?
Freenome (FRNM) is larger, with a market capitalization of $1.70B compared with $1.01B for Lumexa Imaging (LMRI).
Are Freenome and Lumexa Imaging in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.